Muscle mitochondria, function, mass, and quality of life in prostate cancer during androgen deprivation therapy. [PDF]
Caeiro L +12 more
europepmc +1 more source
Correction: Rapid and sustainable deep testosterone reduction predicts effective androgen deprivation therapy for metastatic hormone-sensitive prostate cancer. [PDF]
Wang Z +10 more
europepmc +1 more source
Post-SABR early PSA density kinetics in androgen deprivation therapy-naïve patients: early landmark models for long-term biochemical recurrence-free survival. [PDF]
Greco C +8 more
europepmc +1 more source
Glucagon-like peptide-1 receptor agonist versus other anti-diabetic agents on patients with prostate cancer undergoing androgen-deprivation therapy. [PDF]
Huang SC +5 more
europepmc +1 more source
Quantitative Morphometric Response to Neoadjuvant Androgen-Deprivation Therapy and Its Prognostic Role After Radical Prostatectomy. [PDF]
Afanasiev Y +5 more
europepmc +1 more source
Central and peripheral areal BMD, bone microarchitecture, and strength after initiation of androgen deprivation therapy in men with prostate cancer: a two-year follow-up study. [PDF]
van Oostwaard MM +4 more
europepmc +1 more source
The impact of different exercise modalities on health-related quality of life in patients with prostate cancer undergoing androgen deprivation therapy: a systematic review and network meta-analysis. [PDF]
Li W +7 more
europepmc +1 more source
Impact of Androgen Deprivation Therapy on Lower Urinary Tract Symptoms in Patients with Prostate Cancer. [PDF]
Park TY, Shim SR, Kim CH.
europepmc +1 more source

